Department of Anesthesiology, Weill Cornell Medical Center and New York Presbyterian Hospital, New York, NY 10065, USA.
J Clin Anesth. 2009 Nov;21(7):517-20. doi: 10.1016/j.jclinane.2008.11.013.
Insertion of drug-eluting stents is one of the strategies for treating patients with coronary artery disease. These patients can be a perioperative challenge in management as they need to be maintained on antiplatelet therapy to prevent stent thrombosis, which puts them at an increased risk for surgical bleeding. Recently revised guidelines on elective surgery following insertion of a drug-eluting stent recommend dual antiplatelet therapy for a period of twelve months. The management of a patient who presented for surgery more than two years after the insertion of a drug-eluting stent, and who developed in-stent thrombosis intraoperatively, is presented.
药物洗脱支架置入术是治疗冠状动脉疾病患者的策略之一。这些患者在围手术期管理方面是一个挑战，因为他们需要接受抗血小板治疗以预防支架内血栓形成，这使他们面临更高的手术出血风险。最近修订的关于药物洗脱支架置入术后择期手术的指南建议进行为期 12 个月的双联抗血小板治疗。本文介绍了一位患者在置入药物洗脱支架两年多后因术中发生支架内血栓形成而接受手术的病例。
